查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1875982

单细胞分析全球市场

Single-Cell Analysis
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球单细胞分析市场预计到2030年将达到280亿美元

全球单细胞分析市场规模在2024年估计为101亿美元，预计到2030年将达到280亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为18.6%。本报告分析的细分市场之一—肿瘤学应用，预计将以20.5%的复合年增长率成长，并在分析期结束时达到111亿美元。免疫学应用预计在分析期内将以19.4%的复合年增长率成长。

美国市场规模估计为27亿美元，而中国市场预计将以17.1%的复合年增长率成长。

预计到2024年，美国单细胞分析市场规模将达27亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到41亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）将达到17.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的复合年增长率将分别达到17.1%和15.6%。在欧洲，德国的复合年增长率预计将达到约13.0%。

全球单细胞分析市场—主要趋势与驱动因素摘要

为什么单细胞分析在生物医学研究中变得至关重要？

单细胞分析已成为生物医学研究的关键技术，因为它能够提供极其详尽的细胞异质性讯息，使研究人员能够以前所未有的深度理解复杂的生物系统。与提供细胞群体平均数据的群体细胞分析不同，单细胞分析能够研究单一细胞，揭示其独特的细胞状态和功能。这种能力在肿瘤学、免疫学和发育生物学等领域至关重要，因为在这些领域，理解细胞多样性和行为是阐明疾病机制、发现生物标记和开发标靶治疗的关键。因此，单细胞分析正日益应用于学术研究、药物开发和临床诊断，以推进精准医疗并改善患者预后。

技术进步如何提高单细胞分析的能力？

技术进步显着提升了单细胞分析的能力，提高了资料收集和解读的准确性、通量和可及性。基于高通量单细胞RNA定序（scRNA-seq）、质谱流式细胞仪和微流体技术的平台开发，实现了对数千个单细胞的同步分析，从而能够全面深入了解细胞异质性。此外，整合基因组学、转录组学、蛋白质组学和代谢体学资料的多体学方法创新，拓展了单细胞分析的范围，使其不再局限于RNA表现。人工智慧（AI）和机器学习（ML）在资料分析和解读中的应用，也简化了从复杂资料集中提取有效资讯的过程。这些进步使单细胞分析更加稳健、扩充性且易于使用，促进了其在各种研究和临床环境中的应用。

哪些细分市场正在推动单细胞分析技术的应用？

单细胞分析技术包括耗材（试剂、试剂盒、仪器）及设备（流式细胞仪、质谱仪、定序平台）。单细胞分析的应用领域涵盖癌症研究、免疫学、神经学、干细胞研究和发育生物学，其中癌症研究和免疫学领域由于对肿瘤微环境和免疫细胞谱分析的迫切需求，成为市场的主要驱动力。终端用户包括学术研究机构、製药和生物技术公司、医院和诊断实验室，其中专注于基础研究和转化研究的学术研究机构占据了大部分应用。从区域来看，北美和欧洲是最大的单细胞分析市场，这主要得益于雄厚的研究经费、先进的医疗基础设施以及众多生物技术Start-Ups公司。同时，亚太地区正崛起为高成长地区，这主要得益于不断扩大的生物医学研究活动和日益增长的医疗保健投资。

推动单细胞分析市场成长的关键因素有哪些？

单细胞分析市场的成长受多种因素驱动，包括对精准医疗和标靶治疗日益增长的需求、高通量和多组体学单细胞平台的技术进步，以及单细胞分析在癌症研究、免疫学和神经病学领域应用的不断扩展。使用者友好、自动化和扩充性的单细胞分析系统的开发正在推动学术研究人员、製药公司和临床实验室对该市场的接受度。人工智慧和机器学习在高效数据分析、解读和视觉化方面的应用，正在推动市场在各个终端用户领域的扩张。单细胞分析在药物发现、生物标记开发和个人化治疗策略的应用日益广泛，加上对创新、经济高效且高精度工具的需求，为市场成长创造了新的机会。此外，对非侵入性、无标定和高解析度单细胞分析方法的研发投入不断增加，也进一步推动了市场扩张。

部分：

按应用领域（肿瘤学、免疫学、干细胞、非侵入性产前诊断、神经病学、其他应用）；按应用领域（学术和研究实验室、生物技术和製药公司、医院和诊断实验室、其他应用）

受访公司范例

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KgaA
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Market Glass, Inc. 并没有查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在国、製造地以及进出口（成品和OEM产品）情况，预测企业竞争格局的变化。这种复杂多变的市场现实将对竞争对手产生多方面的影响，包括销货成本增加、盈利下降和供应链重组，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP14756

Global Single-Cell Analysis Market to Reach US$28.0 Billion by 2030

The global market for Single-Cell Analysis estimated at US$10.1 Billion in the year 2024, is expected to reach US$28.0 Billion by 2030, growing at a CAGR of 18.6% over the analysis period 2024-2030. Cancer Application, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Immunology Application segment is estimated at 19.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 17.1% CAGR

The Single-Cell Analysis market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 17.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.1% and 15.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Single-Cell Analysis Market - Key Trends and Drivers Summarized

Why Is Single-Cell Analysis Becoming Indispensable in Biomedical Research?

Single-cell analysis has become indispensable in biomedical research due to its ability to provide highly detailed insights into cellular heterogeneity, allowing researchers to understand complex biological systems at an unprecedented level. Unlike bulk cell analysis, which offers averaged data across a population of cells, single-cell analysis enables the examination of individual cells, revealing unique cellular states and functions. This capability is crucial for fields such as oncology, immunology, and developmental biology, where understanding cellular diversity and behavior is key to identifying disease mechanisms, discovering biomarkers, and developing targeted therapies. As a result, single-cell analysis is increasingly being adopted in academic research, pharmaceutical development, and clinical diagnostics to advance precision medicine and improve patient outcomes.

How Are Technological Advancements Enhancing the Capabilities of Single-Cell Analysis?

Technological advancements are significantly enhancing the capabilities of single-cell analysis by improving the accuracy, throughput, and accessibility of data collection and interpretation. The development of high-throughput single-cell RNA sequencing (scRNA-seq), mass cytometry, and microfluidics-based platforms has enabled the simultaneous analysis of thousands of individual cells, providing a comprehensive view of cellular heterogeneity. Moreover, innovations in multi-omics approaches, which integrate genomics, transcriptomics, proteomics, and metabolomics data, are expanding the scope of single-cell analysis beyond just RNA expression. The integration of artificial intelligence (AI) and machine learning (ML) for data analysis and interpretation is also streamlining the extraction of meaningful insights from complex datasets. These advancements are making single-cell analysis more robust, scalable, and user-friendly, thereby driving its adoption across various research and clinical settings.

Which Market Segments Are Leading the Adoption of Single-Cell Analysis?

Types of single-cell analysis technologies include consumables (reagents, kits, and instruments) and instruments (flow cytometers, mass spectrometers, and sequencing platforms). Applications of single-cell analysis span cancer research, immunology, neurology, stem cell research, and developmental biology, with cancer research and immunology leading the market due to the high demand for understanding tumor microenvironments and immune cell profiling. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and hospitals and diagnostic laboratories, with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for single-cell analysis due to strong research funding, advanced healthcare infrastructure, and a high number of biotech startups, while Asia-Pacific is emerging as a high-growth region driven by expanding biomedical research activities and increasing healthcare investments.

What Are the Key Drivers of Growth in the Single-Cell Analysis Market?

The growth in the single-cell analysis market is driven by several factors, including the rising demand for precision medicine and targeted therapies, technological advancements in high-throughput and multi-omics single-cell platforms, and the increasing use of single-cell analysis in cancer research, immunology, and neurology. The development of user-friendly, automated, and scalable single-cell analysis systems is driving market adoption among academic researchers, pharmaceutical companies, and clinical laboratories. The focus on integrating AI and machine learning for efficient data analysis, interpretation, and visualization is expanding the market reach among diverse end-users. The growing use of single-cell analysis in drug discovery, biomarker development, and personalized treatment strategies, coupled with the demand for innovative, cost-effective, and high-precision tools, is creating new opportunities for market growth. Additionally, the increasing investments in R&D for non-invasive, label-free, and high-resolution single-cell analysis methods are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Single-Cell Analysis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology, Other Applications); End-Use (Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KgaA
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Single-Cell Analysis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine and Targeted Therapies Spurs Single-Cell Analysis Market Growth
    • Technological Advancements in Genomics, Transcriptomics, and Proteomics Strengthen the Business Case for Single-Cell Analysis
    • Increasing Adoption of Single-Cell Analysis in Cancer Research Expands Addressable Market Opportunity
    • Development of High-Throughput and High-Resolution Single-Cell Analysis Platforms Drives Adoption
    • Growing Focus on Understanding Cellular Heterogeneity and Immune System Dynamics Generates New Market Opportunities
    • Integration of Artificial Intelligence and Machine Learning in Data Analysis Throws Spotlight on Single-Cell Analysis Market Potential
    • Expansion of Single-Cell Analysis Applications in Neurology, Immunology, and Developmental Biology Creates New Growth Avenues
    • Development of User-Friendly, Automated, and Multi-Omics Single-Cell Platforms Reinforces Market Adoption
    • Growing Demand for Single-Cell Sequencing in Drug Discovery and Development Sustains Market Growth
    • Focus on Developing Non-Invasive, Label-Free, and High-Precision Single-Cell Analysis Methods Drives Innovation
    • Rising Adoption of Single-Cell Analysis in Clinical Diagnostics and Biomarker Discovery Spurs Market Demand
    • Shift Towards Single-Cell Multi-Omics and Spatial Transcriptomics Strengthens Market Competitiveness
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Single-Cell Analysis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Stem Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Non-Invasive Prenatal Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Academic & Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION